Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Four former Symmetry workers consent to judgment in a lawsuit accusing them of a years-long accounting scheme that inflated Symmetry’s stock price by up to 20% and potentially cost shareholders $120 million.
The $372 million buyout of Navilyst Medical by AngioDynamics (NSDQ:ANGO) is a reset button that will reinforce the combined operation for the future, AngioDynamics CEO Joe DeVivo told MassDevice this afternoon.
After a year of negotiations, the medical device industry and the FDA signed off on a tentative agreement for the next 5 years of med-tech user fees, nearly doubling the industry’s expected buy-in and setting some "game-changing" expectations for the agency.